Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Accumulated Expenses (2016 - 2025)

Nephros (NEPH) has 16 years of Accumulated Expenses data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 257.45% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, up 257.45%, while the annual FY2024 figure was $565000.0, 382.91% up from the prior year.
  • Accumulated Expenses reached $1.2 million in Q3 2025 per NEPH's latest filing, up from $771000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.2 million in Q3 2025 and bottomed at $70000.0 in Q3 2021.
  • Average Accumulated Expenses over 5 years is $415736.8, with a median of $383000.0 recorded in 2023.
  • The widest YoY moves for Accumulated Expenses: up 866.67% in 2021, down 88.26% in 2021.
  • A 5-year view of Accumulated Expenses shows it stood at $232000.0 in 2021, then rose by 22.84% to $285000.0 in 2022, then crashed by 58.95% to $117000.0 in 2023, then surged by 382.91% to $565000.0 in 2024, then skyrocketed by 103.72% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $1.2 million in Q3 2025, $771000.0 in Q2 2025, and $603000.0 in Q1 2025.